MedPal AI plc (LSE:MPAL) has acquired Solid State Technologies Ltd, which trades as eMARx, in a transaction valuing the business at approximately £0.47 million. eMARx provides electronic medication administration record software to UK care homes and pharmacies, and the acquisition adds a recurring, high-margin software business with an established customer base that includes both national care providers and independent operators. The existing eMARx management team will also become long-term shareholders in MedPal AI as part of the transaction.
The acquisition completes the final software component of MedPal’s integrated Health OS platform, linking NHS prescriptions, automated dispensing from the company’s Sarus Court pharmacy hub, medication delivery and barcode-verified administration within care homes. MedPal plans to offer the eMARx platform at little or no cost to care homes that use its pharmacy services exclusively, a strategy designed to accelerate customer adoption, increase pharmacy revenues and improve medication management, safety and oversight for residents, healthcare providers and the NHS across the UK’s £27 billion care home sector.
More about MedPal AI
MedPal AI plc is a UK-based digital healthcare and pharmacy technology company focused on improving medication management across the care home and primary care markets. Its operations include NHS distance-selling pharmacy services, business-to-business pharmacy supply for care homes, a private healthcare clinic and Juno, its AI-powered health assistant.
The company also operates the Sarus Court robotic dispensing hub in Runcorn, which uses BD Rowa automation technology to provide high-volume pharmacy dispensing. By integrating software, pharmacy services and artificial intelligence into a single healthcare platform, MedPal AI aims to streamline the medicines supply chain and strengthen its position in the growing UK care home market.
Leave a Reply